NASDAQ: ARRYArray Technologies Inc Stock
$10.96-0.38 (-3.35%)
Updated May 17, 2024
ARRY Price
$10.96
Fair Value Price
$17.52
Market Cap
$1.66B
52 Week Low
$10.82
52 Week High
$26.64
P/E
26.73x
P/B
7.19x
P/S
1.67x
PEG
0.3x
Dividend Yield
N/A
Revenue
$1.35B
Earnings
$113.27M
Gross Margin
27.8%
Operating Margin
13.71%
Profit Margin
4.5%
Debt to Equity
4.47
Operating Cash Flow
$234M
Beta
1.83
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ARRY Overview
Array Technologies, Inc. manufactures and supplies solar tracking systems and related products in the United States and internationally. Its products include DuraTrack HZ v3, a single-axis solar tracking system; and SmarTrack, a machine learning software that is used to identify the optimal position for a solar array in real time to increase energy production. The company was founded in 1989 and is headquartered in Albuquerque, New Mexico.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ARRY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARRY ($10.96) is undervalued by 37.43% relative to our estimate of its Fair Value price of $17.52 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ARRY ($10.96) is significantly undervalued by 37.43% relative to our estimate of its Fair Value price of $17.52 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ARRY ($10.96) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ARRY due diligence checks available for Premium users.
Be the first to know about important ARRY news, forecast changes, insider trades & much more!
ARRY News
Valuation
ARRY fair value
Fair Value of ARRY stock based on Discounted Cash Flow (DCF)
Price
$10.96
Fair Value
$17.52
Undervalued by
37.43%
ARRY ($10.96) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ARRY ($10.96) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ARRY ($10.96) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ARRY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
26.73x
Industry
24.31x
Market
30.97x
ARRY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ARRY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ARRY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.19x
Industry
2.67x
ARRY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARRY price to earnings growth (PEG)
For valuing profitable companies with growth potential
ARRY is good value based... subscribe to Premium to read more.
PEG Value Valuation
ARRY's financial health
Profit margin
Revenue
$153.4M
Net Income
$2.2M
Profit Margin
-7.4%
ARRY's Earnings (EBIT) of $185.59M... subscribe to Premium to read more.
Interest Coverage Financials
ARRY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$1.0B
Debt to equity
4.47
ARRY's short-term assets ($774.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARRY's short-term assets ($774.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARRY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$47.5M
Investing
-$2.4M
Financing
-$4.6M
ARRY's operating cash flow ($233.64M)... subscribe to Premium to read more.
Debt Coverage Financials
ARRY vs Solar Stocks
Array Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.